Trial Information

Summary: No More UC – A research study for adults with mild to moderate ulcerative colitis currently in remission.

We are seeking participants for a clinical study to test the safety and effectiveness of encapsulated mesalamine pellets, an investigational medication, for maintenance of remission of mild to moderate ulcerative colitis. The study is comparing the investigational medication to placebo in people who have been diagnosed with ulcerative colitis that is in remission.

To qualify for the study, you must at least meet the conditions listed below:

• You must be at least 18 years old.
• You must be in remission from ulcerative colitis for at least one month but no longer than 12 months.
• You must not have a history of allergy or intolerance to aspirin, mesalamine or other salicylates.
• You must not have phenylketonuria.
• You must not have received immunosuppressive therapy within 30 days prior to screening, or oral, IV, or topical rectal corticosteroids within 30 days prior to screening.
• You must not have had any prior bowel surgery, excepting appendectomy.

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:39 AM